Industry + Organization Newswire

Novartis to Start Large, Randomized Trial of Hydroxychloroquine in Hospitalized COVID-19 Patients

by Global Biodefense Staff April 20, 2020, 9:58 am
IDEXX Makes Test for COVID-19 Available to Veterinarians Amid Rare Cases of Human-to-Pet Transmission

by Global Biodefense Staff April 20, 2020, 9:47 am
Alexion to Initiate Phase 3 Study of Rare Blood-Disorder Drug in Severe COVID-19 Patients

by Global Biodefense Staff April 20, 2020, 8:55 am
BARDA and Hememics Collaborate to Develop Rapid Diagnostic to Identify SARS-CoV-2

by Global Biodefense Staff April 17, 2020, 6:37 pm
BARDA and Sanofi Prepare for Studies of COVID-19 Vaccine

by Global Biodefense Staff April 17, 2020, 6:00 pm
FDA Accepts for Priority Review for REGN-EB3 to Treat Ebola

by Global Biodefense Staff April 16, 2020, 4:03 pm
Abbott Launches Laboratory-Based Antibody Blood Test with Manufacturing Scaling Targets

by Global Biodefense Staff April 15, 2020, 3:58 pm
BARDA Facilitates Development of Immunotherapies for COVID-19 Patients

by Global Biodefense Staff April 14, 2020, 5:09 pm
BARDA and Vela Diagnostics partner to develop rapid diagnostic test for the COVID-19

by Global Biodefense Staff April 14, 2020, 3:50 pm
Ridgeback Receives UK Clearance to Begin Human Testing of Antiviral for COVID-19

by Global Biodefense Staff April 14, 2020, 3:00 pm
BARDA Supports DiaSorin to Develop a Fully Automated Serology Test to Detect COVID-19 Infections

by Global Biodefense Staff April 13, 2020, 5:00 pm
Lilly Begins Clinical Testing of Therapies for COVID-19

by Global Biodefense Staff April 11, 2020, 3:18 pm
Rapid Lab-Free PCR COVID-19 Test in Development by DnaNudge and Imperial College

by Global Biodefense Staff April 10, 2020, 8:02 pm
DuPont to Produce up to 4.5 Million TYVEK Protective Suits for U.S. Healthcare Workers

by Global Biodefense Staff April 9, 2020, 9:12 am

Congratulations. You've reached the end of the internet.

Archives: Newswire

Novartis to Start Large, Randomized Trial of Hydroxychloroquine in Hospitalized COVID-19 Patients

IDEXX Makes Test for COVID-19 Available to Veterinarians Amid Rare Cases of Human-to-Pet Transmission

Alexion to Initiate Phase 3 Study of Rare Blood-Disorder Drug in Severe COVID-19 Patients

BARDA and Hememics Collaborate to Develop Rapid Diagnostic to Identify SARS-CoV-2

BARDA and Sanofi Prepare for Studies of COVID-19 Vaccine

FDA Accepts for Priority Review for REGN-EB3 to Treat Ebola

Abbott Launches Laboratory-Based Antibody Blood Test with Manufacturing Scaling Targets

BARDA Facilitates Development of Immunotherapies for COVID-19 Patients

BARDA and Vela Diagnostics partner to develop rapid diagnostic test for the COVID-19

Ridgeback Receives UK Clearance to Begin Human Testing of Antiviral for COVID-19

BARDA Supports DiaSorin to Develop a Fully Automated Serology Test to Detect COVID-19 Infections

Lilly Begins Clinical Testing of Therapies for COVID-19

Rapid Lab-Free PCR COVID-19 Test in Development by DnaNudge and Imperial College

DuPont to Produce up to 4.5 Million TYVEK Protective Suits for U.S. Healthcare Workers

The Role Nuclear-Related Techniques Play in Fighting Zoonotic Diseases

Relief Funds Being Used to Pay Hospital Shareholders at the Expense of Frontline Health Care Workers

The U.S. Isn’t In a Second Wave of Coronavirus – the First Wave Never Ended

Coronavirus Can Cause Lasting Lung Damage – But the Effects May Ease Over Time

Researchers Identify Multiple Molecules that Shut Down SARS-Cov-2 Polymerase Reaction

Bioxy Decontaminant Agent Tested by DoD Shown Effective Against COVID-19

Air Force COVID-19 Medical Transport: Portable Biocontainment Care Module

CCDC Chemical Biological Center Strives to Become DoD’s Biomanufacturing Leader

Air Force Bioenvironmental Engineers Expand Mission in Aerovac, Close Workspaces

Rapid-Release Gases to Speed Up Cleaning of COVID-19 Ambulances

Chasing the Antidote for Deadly Nerve Agents

Latest Articles